Thioredoxin-Interacting Protein Gene Expression via MondoA Is Rapidly and Transiently Suppressed during Inflammatory Responses

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Kanari, Yasuyoshi ^a,b   Sato, Yuki ^a   Aoyama, Satoru ^a   Muta, Tatsushi ^a,b  

^a TOHOKU UNIVERSITY   (Japan)

^b Center for Ecosystem Management Adapting to Global Change   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; FORKHEAD TRANSCRIPTION FACTOR; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; IODOACETIC ACID; LIGAND; LIPOPOLYSACCHARIDE; MESSENGER RNA; THIOREDOXIN INTERACTING PROTEIN; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MONDOA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DISULFIDE BOND; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; GENE PRODUCT; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MACROPHAGE; METABOLIC REGULATION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROTEIN INTERACTION;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; GENE EXPRESSION REGULATION; GLUCOSE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NIH 3T3 CELLS; RNA, MESSENGER; THIOREDOXINS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84874764451     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059026     Document Type: Article

References (36)

1. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
2. Chen KS, DeLuca HF, (1994) Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyvitamin D-3. Biochimica et biophysica acta 1219: 26-32.
3. Kim SY, Suh HW, Chung JW, Yoon SR, Choi I, (2007) Diverse Functions of VDUP1 in Cell Proliferation, Differentiation, and Diseases. Cell Mol Immunol 4: 345-351.
4. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, et al. (1999) Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650.
5. Junn E, Han SH, Im JY, Yang Y, Cho EW, et al. (2000) Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. Journal of immunology 164: 6287-6295.
6. Bodnar JS, Chatterjee A, Castellani LW, Ross DA, Ohmen J, et al. (2002) Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat Genet 30: 110-116.
7. Sheth SS, Castellani LW, Chari S, Wagg C, Thipphavong CK, et al. (2005) Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition. Journal of lipid research 46: 123-134.
8. Oka S, Liu W, Masutani H, Hirata H, Shinkai Y, et al. (2006) Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. Faseb J 20: 121-123.
9. Yoshioka J, Imahashi K, Gabel SA, Chutkow WA, Burds AA, et al. (2007) Targeted deletion of thioredoxin-interacting protein regulates cardiac dysfunction in response to pressure overload. Circ Res 101: 1328-1338.
10. Hui ST, Andres AM, Miller AK, Spann NJ, Potter DW, et al. (2008) Txnip balances metabolic and growth signaling via PTEN disulfide reduction. Proceedings of the National Academy of Sciences of the United States of America 105: 3921-3926.
11. Lee KN, Kang HS, Jeon JH, Kim EM, Yoon SR, et al. (2005) VDUP1 is required for the development of natural killer cells. Immunity 22: 195-208.
12. Stoltzman CA, Peterson CW, Breen KT, Muoio DM, Billin AN, et al. (2008) Glucose sensing by MondoA:Mlx complexes: a role for hexokinases and direct regulation of thioredoxin-interacting protein expression. Proceedings of the National Academy of Sciences of the United States of America 105: 6912-6917.
13. Yu FX, Luo Y, (2009) Tandem ChoRE and CCAAT motifs and associated factors regulate Txnip expression in response to glucose or adenosine-containing molecules. PloS one 4: e8397.
14. Peterson CW, Stoltzman CA, Sighinolfi MP, Han KS, Ayer DE, (2010) Glucose controls nuclear accumulation, promoter binding, and transcriptional activity of the MondoA-Mlx heterodimer. Molecular and Cellular Biology 30: 2887-2895.
15. Parikh H, Carlsson E, Chutkow WA, Johansson LE, Storgaard H, et al. (2007) TXNIP regulates peripheral glucose metabolism in humans. PLoS medicine 4: e158.
16. Patwari P, Chutkow WA, Cummings K, Verstraeten VL, Lammerding J, et al. (2009) Thioredoxin-independent regulation of metabolism by the α-arrestin proteins. The Journal of biological chemistry 284: 24996-25003.
17. Yoshihara E, Fujimoto S, Inagaki N, Okawa K, Masaki S, et al. (2010) Disruption of TBP-2 ameliorates insulin sensitivity and secretion without affecting obesity. Nat Commun 1: 127.
18. Loots GG, Ovcharenko I, (2004) rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic acids research 32: W217-221.
19. Sakiyama H, Wynn RM, Lee WR, Fukasawa M, Mizuguchi H, et al. (2008) Regulation of nuclear import/export of carbohydrate response element-binding protein (ChREBP): interaction of an α-helix of ChREBP with the 14-3-3 proteins and regulation by phosphorylation. The Journal of biological chemistry 283: 24899-24908.
20. Ge Q, Nakagawa T, Wynn RM, Chook YM, Miller BC, et al. (2011) Importin-α protein binding to a nuclear localization signal of carbohydrate response element-binding protein (ChREBP). The Journal of biological chemistry 286: 28119-28127.
21. Mousa SA, Gallati C, Simone T, Dier E, Yalcin M, et al. (2009) Dual targeting of the antagonistic pathways mediated by Sirt1 and TXNIP as a putative approach to enhance the efficacy of anti-aging interventions. Aging 1: 412-424.
22. Yu FX, Chai TF, He H, Hagen T, Luo Y, (2010) Thioredoxin-interacting protein (Txnip) gene expression: sensing oxidative phosphorylation status and glycolytic rate. J Biol Chem 285: 25822-25830.
23. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643.
24. Zhang P, Wang C, Gao K, Wang D, Mao J, et al. (2010) The ubiquitin ligase itch regulates apoptosis by targeting thioredoxin-interacting protein for ubiquitin-dependent degradation. The Journal of biological chemistry 285: 8869-8879.
25. Elgort MG, O'Shea JM, Jiang Y, Ayer DE, (2010) Transcriptional and Translational Downregulation of Thioredoxin Interacting Protein Is Required for Metabolic Reprogramming during G(1). Genes & cancer 1: 893-907.
26. Shao W, Yu Z, Fantus IG, Jin T, (2010) Cyclic AMP signaling stimulates proteasome degradation of thioredoxin interacting protein (TxNIP) in pancreatic β-cells. Cellular signalling 22: 1240-1246.
27. Kaadige MR, Looper RE, Kamalanaadhan S, Ayer DE, (2009) Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity. Proceedings of the National Academy of Sciences of the United States of America 106: 14878-14883.
28. Eilers AL, Sundwall E, Lin M, Sullivan AA, Ayer DE, (2002) A novel heterodimerization domain, CRM1, and 14-3-3 control subcellular localization of the MondoA-Mlx heterocomplex. Molecular and cellular biology 22: 8514-8526.
29. Sans CL, Satterwhite DJ, Stoltzman CA, Breen KT, Ayer DE, (2006) MondoA-Mlx heterodimers are candidate sensors of cellular energy status: mitochondrial localization and direct regulation of glycolysis. Molecular and cellular biology 26: 4863-4871.
30. Fox CJ, Hammerman PS, Thompson CB, (2005) Fuel feeds function: energy metabolism and the T-cell response. Nature reviews Immunology 5: 844-852.
31. Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, et al. (2011) Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. Journal of immunology 186: 3299-3303.
32. Shi LZ, Wang R, Huang G, Vogel P, Neale G, et al. (2011) HIF1α-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. The Journal of experimental medicine 208: 1367-1376.
33. Rodríguez-Prados JC, Través PG, Cuenca J, Rico D, Aragonés J, et al. (2010) Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. Journal of immunology 185: 605-614.
34. Sag D, Carling D, Stout RD, Suttles J, (2008) Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. Journal of immunology 181: 8633-8641.
35. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, et al. (2010) Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 11: 897-904.
36. Agata Y, Katakai T, Ye SK, Sugai M, Gonda H, et al. (2001) Histone acetylation determines the developmentally regulated accessibility for T cell receptor γ gene recombination. The Journal of experimental medicine 193: 873-880.